CSIMarket Company Name, Ticker, Customers, else..
 
Neuphoria Therapeutics Inc   (NASDAQ: NEUP)
 
Price: $3.4700 $-0.04 -1.140%
Day's High: $3.5899999141693115 Week Perf: -4.93 %
Day's Low: $ 3.46 30 Day Perf: -7.47 %
Volume (M): 12,362 52 Wk High: $ 21.40
Volume (M$): $ 0 52 Wk Avg: $4.83
Open: $3.59 52 Wk Low: $3.19



 Market Capitalization (Millions $) 15
 Shares Outstanding (Millions) 4
 Employees -
 Revenues (TTM) (Millions $) 1
 Net Income (TTM) (Millions $) -13
 Cash Flow (TTM) (Millions $) 5
 Capital Exp. (TTM) (Millions $) 0

Business Description


Neuphoria Therapeutics Inc., formerly Bionomics Limited, is a biopharmaceutical company that re-domiciled from Australia to Delaware in 2024. The company focuses on drug discovery and development, conducting clinical trials and preclinical studies to develop product candidates for various diseases, with plans for commercialization.


   Company Address: 100 Summit Drive Burlington 1803 MA
   Company Phone Number: 730-6665   Stock Exchange / Ticker: NASDAQ NEUP


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
VTGN        4.07% 
• View Complete Report
   



Management Announcement

Neuphoria Therapeutics Reports Strong First Quarter 2025 Business Updates Amid Promising Stock Performance

Published Tue, May 20 2025 8:23 PM UTC

Neuphoria Therapeutics Reports Strong First Quarter 2025 Business Updates Amid Promising Stock PerformanceBURLINGTON, Mass. May 20, 2025 – Neuphoria Therapeutics Inc. (Nasdaq: NEUP), a forward-thinking, clinical-stage biotechnology firm specializing in innovative treatments for neuropsychiatric disorders, has released significant business updates for the first quarter of 2...



Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) -
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) 12.99
Price to Sales (Expected) -
Price to Book 0.62
PEG (TTM) -

Financial Strength Current
Quick Ratio 26.26
Working Capital Ratio 27.85
Leverage Ratio (MRQ) 0.17
Total Debt to Equity -
Interest Coverage (TTM) -
Debt Coverage (TTM) -

Per Share Current
Earnings (TTM) -410.42 $
Revenues (TTM) 0.27 $
Cash Flow (TTM) 1.17 $
Cash 4.52 $
Book Value 5.6 $
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) -
Net Income per Employee (TTM) -
Receivable Turnover Ratio (TTM) 1.33
Inventory Turnover Ratio (TTM) -
Asset Turnover Ratio (TTM) 0.03

Profitability Ratios Current
Gross Margin (MRQ) 0 %
Operating Margin (MRQ) -470.63 %
Net Margin (MRQ) -417.7 %
Net Cash Flow Margin (MRQ) 0 %
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) -
Return On Investment (TTM) -
Return On Equity (TTM) -
Dividend Yield -
Pay out Ratio (TTM) -






Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.